Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants
EBITDA for the period rose by 23.2% to Rs. 3,797 million
Shelter Pharma Limited is set to capitalize on the growing demand for natural health products in India
EBITDA before special items decreases to €4.08 billion (7.4%)
The Board of Directors of the company recommends a final dividend of Rs. 42 per equity share for the 12 months period ended March 31, 2025
This marks yet another milestone in our series of successful audits over the past year
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
ekincare has raised a total funding of $22M since 2015 till date
Trastuzumab specifically binds and inhibits the human epidermal growth factor receptor 2 (HER2) protein
Subscribe To Our Newsletter & Stay Updated
